A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection

NCT00820053 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: epirubicin and lipiodol

Sponsor

Eastern Hepatobiliary Surgery Hospital